1258939007: Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Salicylate-containing product\Mesalazine-containing product\Mesalazine only product\Mesalazine only product in oral dose form\Mesalazine 1.2 g prolonged-release oral tablet
• \Medicinal product categorised by structure\Organic acid and/or organic acid derivative-containing product\Carboxylic acid and/or carboxylic acid derivative-containing product\Salicylate-containing product\Mesalazine-containing product\Mesalazine-containing product in oral dose form\Mesalazine only product in oral dose form\Mesalazine 1.2 g prolonged-release oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Amino acid derivative-containing product\Mesalazine-containing product\Mesalazine only product\Mesalazine only product in oral dose form\Mesalazine 1.2 g prolonged-release oral tablet
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Amino acid derivative-containing product\Mesalazine-containing product\Mesalazine-containing product in oral dose form\Mesalazine only product in oral dose form\Mesalazine 1.2 g prolonged-release oral tablet
• \Medicinal product categorised by structure\Phenol structure-containing product\Mesalazine-containing product\Mesalazine only product\Mesalazine only product in oral dose form\Mesalazine 1.2 g prolonged-release oral tablet
• \Medicinal product categorised by structure\Phenol structure-containing product\Mesalazine-containing product\Mesalazine-containing product in oral dose form\Mesalazine only product in oral dose form\Mesalazine 1.2 g prolonged-release oral tablet
• \Product manufactured as oral dose form\Mesalazine-containing product in oral dose form\Mesalazine only product in oral dose form\Mesalazine 1.2 g prolonged-release oral tablet

Status: current, Defined. Date: 30-Nov 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5155122011	Product containing precisely mesalazine 1.2 gram/1 each prolonged-release oral tablet (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
5155123018	Mesalazine 1.2 g prolonged-release oral tablet	en	Synonym	Active	Case insensitive	SNOMED CT core
5155124012	Mesalamine 1.2 g prolonged-release oral tablet	en	Synonym	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start